Home
Conditions
Oligometastatic Disease

Clinical trial condition

Oligometastatic Disease

Explore clinical trials studying Oligometastatic Disease. Study availability and eligibility vary by location and protocol.

34 public trials 22 recruiting studies

Refine in advanced search Browse all conditions

Oligometastatic Disease trial results

Recruiting

Phase 2 Study of SBRT Plus Tislelizumab and Regorafenib in Unresectable or Oligometastatic HCC

NCT05917431

Conditions: Oligometastatic Disease, Unresectable Hepatocellular Carcinoma
Locations: Peking University Cancer Hospital Beijing, Beijing Municipality, China

View Trial Details

Recruiting

Stereotactic Ablative Radiotherapy for OligoMetastatic Breast Cancer

NCT05377047

Conditions: Breast Cancer Stage IV, Breast Diseases, Breast Neoplasms, +5 more
Locations: Sahlgrenska University Hospital Gothenburg, Västra Götalandsregionen, Sweden

View Trial Details

Not Yet Recruiting

MRI-Guided Adaptive Radiotherapy for Limited Peritoneal Metastases (MARACAS Trial).

NCT07593261

Conditions: Abdominal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, +7 more
Locations: Gemelli ART (Advanced Radiation Therapy)-Fondazione Policlinico Universitario Agostino Gemelli IRCCS Roma, Italy

View Trial Details

Not Yet Recruiting

125I Seed Implantation Plus Systemic Therapy for Oligoprogressive NSCLC or Colorectal Cancer

NCT07333651

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +17 more
Locations: The 960th Hospital of People's Liberation Army (PLA) Jinan, Shandong, China

View Trial Details

Not Yet Recruiting

Feasibility Trial of Darwin OncoTreat and OncoTarget Precision Medicine Testing

NCT06842030

Conditions: Feasibility, Oligometastatic Disease, Personalized Medicine
Locations: Good Samaritan University Hospital West Islip, New York, United States

View Trial Details

Not Yet Recruiting

Outcomes of Local Treatment for Oligometastatic Prostate Cancer Diagnosed Using PSMA PET Imaging: OLIGOMET Study

NCT06430411

Conditions: Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +13 more
Locations: Not specified

View Trial Details

Completed

Study of PD-1 Antibody Combined With Chemoradiotherapy in Oligometastatic Esophageal Cancer

NCT04821765

Conditions: Chemoradiotherapy, Digestive System Diseases, Digestive System Neoplasms, +10 more
Locations: Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC) Beijing, Beijing Municipality, China

Department 4th of Radiation Oncology, Anyang Cancer Hospital Anyang, Henan, China

View Trial Details

Completed

Efficacy and Safety of SBRT in Oligo-metastatic/Persistent/Recurrent Ovarian Cancer

NCT04593381

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +14 more
Locations: Responsible Research Hospital Campobasso, CB, Italy

S.C. di Radioterapia Oncologica-Azienda Sanitaria locale Biella, Italy

Azienda Ospedaliera "Cannizzaro" Catania, Italy

Azienda sanitaria locale Lanciano Vasto Chieti Chieti, Italy

View all 14 locations

View Trial Details

Completed

Percutaneous High-dose Radiotherapy in Patients With Oligometastases of Prostate Carcinoma

NCT02264379

Conditions: Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +9 more
Locations: Technische Universität Dresden, University Hospital Carl Gustav Carus, Department of Radiation Therapy and Radiation Oncology Dresden, Saxony, Germany

Universitätsklinikum Tübingen, Department of Radiation Therapy and Radiation Oncology Tübingen, Germany

View Trial Details

Active, Not Recruiting

Focal Radiation With Pulsed Systemic Therapy of Abiraterone, Androgen Deprivation Therapy (ADT), Lynparza Towards Castration Sensitive Oligometastatic Prostate Cancer (FAALCON)

NCT04748042

Conditions: Castrate Sensitive Prostate Cancer, Genital Diseases, Genital Diseases, Male, +10 more
Locations: University of Michigan Rogel Cancer Center Ann Arbor, Michigan, United States

View Trial Details

Oligometastatic Disease

Oligometastatic Disease trial results

Related conditions